These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis? Rysavá R, Kalousová M, Zima T, Dostál C, Merta M, Tesar V. Kidney Blood Press Res; 2007; 30(1):1-7. PubMed ID: 17191033 [Abstract] [Full Text] [Related]
8. Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Capeillère-Blandin C, Gausson V, Nguyen AT, Descamps-Latscha B, Drüeke T, Witko-Sarsat V. Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719 [Abstract] [Full Text] [Related]
9. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJ. Int J Cardiol; 2006 May 10; 109(2):275-6. PubMed ID: 15946754 [Abstract] [Full Text] [Related]
10. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Skvarilová M, Bulava A, Stejskal D, Adamovská S, Bartek J. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun 10; 149(1):83-7. PubMed ID: 16170393 [Abstract] [Full Text] [Related]
11. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Antolini F, Valente F, Ricciardi D, Baroni M, Fagugli RM. Clin Chim Acta; 2005 Aug 10; 358(1-2):87-94. PubMed ID: 15885684 [Abstract] [Full Text] [Related]
12. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M. Diabetes Metab Res Rev; 2008 Oct 10; 24(7):549-53. PubMed ID: 18613218 [Abstract] [Full Text] [Related]
13. Protein oxidation status in patients with ankylosing spondylitis. Yazici C, Köse K, Calis M, Kuzugüden S, Kirnap M. Rheumatology (Oxford); 2004 Oct 10; 43(10):1235-9. PubMed ID: 15292529 [Abstract] [Full Text] [Related]
14. The plasma concentration of advanced oxidation protein products and arterial stiffness in apparently healthy adults. Wykretowicz A, Adamska K, Krauze T, Guzik P, Szczepanik A, Rutkowska A, Wysoki H. Free Radic Res; 2007 Jun 10; 41(6):645-9. PubMed ID: 17516236 [Abstract] [Full Text] [Related]
15. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients. Zhou Q, Wu S, Jiang J, Tian J, Chen J, Yu X, Chen P, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Xie DI, Liu J, Xu X, Liang M, Hou F. Nephrology (Carlton); 2012 Sep 10; 17(7):642-9. PubMed ID: 22738256 [Abstract] [Full Text] [Related]
19. A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP). Veyseller B, Aksoy E, Ertaş B, Keskin M, Ozturan O, Yildirim YS, Bayraktar EG, Oztürk H. B-ENT; 2010 May 18; 6(2):105-9. PubMed ID: 20681362 [Abstract] [Full Text] [Related]
20. Protein thiol oxidation and lipid peroxidation in patients with uraemia. Prakash M, Upadhya S, Prabhu R. Scand J Clin Lab Invest; 2004 May 18; 64(6):599-604. PubMed ID: 15370466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]